Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Laura Christine Cappelli, M.D., M.H.S., M.S.
Instructor of Medicine
Expertise: Internal Medicine, Rheumatology
Research Interests: Arthritis; Rheumatology; Inflammation
Johns Hopkins Bayview Medical Center
5200 Eastern Ave.
Mason F. Lord Building, Center Tower Suite 4100
Baltimore, MD 21224 map
Dr. Laura Cappelli is an instructor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and rheumatology.
Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency and performed a fellowship in rheumatology at the Johns Hopkins Hospital.
Dr. Cappelli's research focuses on inflammatory arthritis. Specifically, she studies inflammatory arthritis due to immunotherapy treatments for cancer and rheumatoid arthritis.
- Instructor of Medicine
- MD, Johns Hopkins University School of Medicine (2010)
- Johns Hopkins University School of Medicine / Internal Medicine (2013)
- Johns Hopkins University School of Medicine / Rheumatology (2016)
- American Board of Internal Medicine / Internal Medicine (2013)
Research & Publications
Cappelli LC, Gutierrez AK, Baer AN, Albayda J, Manno RL, Haque U, Lipson EJ, Bleich KB, Shah AA, Naidoo J, Brahmer JR, Le D, Bingham CO 3rd. Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab. Ann Rheum Dis. 2017 Jan;76(1):43-50. doi: 10.1136/annrheumdis-2016-209595. PMID: 27890174
Cappelli LC, Gutierrez AK, Bingham CO 3rd, Shah AA. Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature. Arthritis Care Res (Hoboken). 2016 Dec 20. doi: 10.1002/acr.23177. [Epub ahead of print] PMID: 27998041
Cappelli LC, Shah AA, Bingham CO 3rd. Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology. Rheum Dis Clin North Am. 2017 Feb;43(1):65-78. doi: 10.1016/j.rdc.2016.09.007. PMID: 27890174
Cappelli LC, Shah AA, Bingham CO 3rd. Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities. RMD Open. 2016 Sep 28;2(2):e000321. PMID:27752360
Cappelli, L and Wigley, F. Management of Raynaud's Phenomenon and Digital Ulcers. Rheum Dis Clin North Am. 2015 Aug;41(3):419-38.
Videos & Media
Recent News Articles and Media Coverage
Arthritis Emerges After Cancer Immunotherapy, Medpage Today, (June 17, 2016)
Checkpoint Inhibitors Linked to Inflammatory Arthritis, Medscape (June 29, 2016)
Checkpoint Inhibitor Biologics Linked To Inflammatory Arthritis and Sicca Syndrome, MedicalResearch.com (June 27, 2016)